At Investor Conferences


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Collaboration › Details

Voluntis–Salesforce: CRM software, 201912– collab using Salsesforce cloud + analytics s/w to implement VPS DTx prescription + reimbursement


Period Period 2019-12-16
Organisation Partner, 1st Voluntis S.A. (Euronext Paris: VTX)
  Group Voluntis (Group)
Product Product  Voluntis Practice Solutions (VPS)

Voluntis S.A.. (12/16/19). "Press Release: Voluntis Collaborates with Salesforce to Introduce Full-Service Platform for Digital Therapeutics Prescription and Reimbursement". Cambridge, MA & San Francisco, CA.

Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960), a leader in digital therapeutics (DTx), today announced its collaboration with Salesforce, the global leader in CRM, to implement Voluntis Practice Solutions (VPS), its full-service platform supporting DTx prescription and reimbursement. Salesforce’s Health Cloud, Community Cloud, Sales Cloud and Einstein Analytics solutions will be deployed together to power VPS.

Healthcare professionals often need support when integrating digital therapeutics into their daily clinical workflows, as well as securing reimbursement for the new activities they perform to remotely manage patients along their treatment journey. Voluntis has introduced one of the industry’s most comprehensive suite of services to address these needs, starting in the field of diabetes. Through this partnership with Salesforce, Voluntis will aim to automate these administrative tasks, making it seamless for providers to adopt digital therapeutics in their daily practice. Additionally, the use of AI will help identify and predict users’ behaviors, supporting timely and highly personalized interactions that will contribute to extended patient engagement, improved treatment outcomes and more efficient clinic management.

The initial focus of the platform, planned to go live in Q2 2020, is to support practices using Voluntis’ proprietary solutions in the United States, and to automate the support of provider billing and revenue cycle management activities. The platform will integrate the most recent CPT codes established by Centers for Medicare & Medicaid Services (CMS) to encourage the adoption of digital technologies for chronic disease management.

The partnership is designed to enable future extensions of the platform to third-party digital health solutions, additional geographies, and other provider payment models, including value-based contracting.

“We are delighted to meet the growing demands of practices with a full-service platform built on a market-leading CRM solution,” said Pierre Leurent, Chief Executive Officer, Voluntis. “Salesforce products, analytics and AI represent a perfect fit as we aim to deliver an unrivaled user experience for our solutions. We look forward to this collaboration as we continue to scale our digital therapeutics business.”

“Digital therapeutics is one of the fastest-growing sectors in digital health, and this collaboration is a great illustration of how Health Cloud can enable innovative use cases leveraging best-in-class patient engagement technologies to improve chronic disease management,” said Ashwini Zenooz, MD, SVP and GM for Healthcare and Life Sciences, Salesforce. “We are excited to partner with Voluntis and help advance its leadership in the digital therapeutics space.”


Amélie Janson
+33 1 80 03 19 52

Record changed: 2020-03-19


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Voluntis (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

» top